Lipid-lowering therapy and risk of coronary events.
Lardinois, Claude K
Lipid-lowering therapy and risk of coronary events. [electronic resource] - JAMA - 2071; author reply 2071-2 p. digital
Publication Type: Comment; Letter
0098-7484
10.1001/jama.289.16.2071-b doi
Anticholesteremic Agents--therapeutic use
Cardiovascular Diseases--blood
Cholesterol, HDL--blood
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypercholesterolemia--complications
Hypertension--complications
Risk Factors
Lipid-lowering therapy and risk of coronary events. [electronic resource] - JAMA - 2071; author reply 2071-2 p. digital
Publication Type: Comment; Letter
0098-7484
10.1001/jama.289.16.2071-b doi
Anticholesteremic Agents--therapeutic use
Cardiovascular Diseases--blood
Cholesterol, HDL--blood
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypercholesterolemia--complications
Hypertension--complications
Risk Factors